Special Report on
AIB Capital Markets Structured Finance
AIB Capital Markets Structured Finance - Trends
Latest Trending Story:
With equity markets in negative territory for the third year in a row, economic growth slowing and private investors becoming increasingly risk-averse, it is all too easy to succumb to pessimism. Only two IPOs (C&C and Spectel) have been attempted on the Irish market this year, and both have been aborted at the last minute. This has given rise to concerns that the capacity of the stock market to provide equity capital to Irish companies has diminished. Add in the implosion of the tech sector, the collapse of Elan and the buyouts of eircom, Smurfit Group and Green Property, and it is easy to paint a picture of a market in ...
(AMEX:ANX) is a development-stage specialty pharmaceutical company. It is focused on in-licensing, developing and commercializing product candidates for the treatment of cancer. The Company’s principal product candidates, ANX-530 (vinorelbine injectable emulsion) and ANX-514 (docetaxel injectable emulsion), are emulsion formulations of chemotherapy drugs. AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) is a drug development company specialized in oncology and endocrine therapy. The Company’s product pipeline encompasses compounds at all stages of development, from drug discovery through ... Read More